Narrative Update • Aug 06
Have your own idea? Try our Stock Screener
Indian (NIFTY) Clinical Research and Equipment Industry Analysis
UpdatedAug 07, 2026
DataAggregated Company Financials
Companies22
- 7D5.0%
- 3M16.2%
- 1Y20.3%
- YTDn/a
The Clinical Research and Equipment industry is up 5.0% in the last week, with Divi's Laboratories up 6.6%. Meanwhile, OneSource Specialty Pharma actually underperformed within the industry, shrinking 7.8% in the last week. In the last 12 months, the industry was up 20%. Earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 07 Aug 2026 | ₹3.8t | ₹370.4b | ₹49.3b | 39.2x | 77.5x | 10.3x |
| Sun, 05 Jul 2026 | ₹3.3t | ₹361.8b | ₹46.4b | 40.8x | 72.1x | 9.2x |
| Tue, 02 Jun 2026 | ₹3.3t | ₹362.2b | ₹46.3b | 34.5x | 70.5x | 9x |
| Thu, 30 Apr 2026 | ₹3.2t | ₹350.7b | ₹46.3b | 31.5x | 68.6x | 9.1x |
| Sat, 28 Mar 2026 | ₹2.9t | ₹350.2b | ₹46.2b | 28x | 61.9x | 8.2x |
| Mon, 23 Feb 2026 | ₹2.9t | ₹350.2b | ₹46.2b | 28.1x | 63.6x | 8.4x |
| Wed, 21 Jan 2026 | ₹2.9t | ₹342.6b | ₹48.4b | 30x | 60x | 8.5x |
| Fri, 19 Dec 2025 | ₹3.1t | ₹342.6b | ₹48.4b | 32x | 64x | 9x |
| Sun, 16 Nov 2025 | ₹3.1t | ₹338.6b | ₹47.7b | 46.8x | 65.9x | 9.3x |
| Tue, 14 Oct 2025 | ₹3.3t | ₹331.4b | ₹45.5b | 44.4x | 71.6x | 9.8x |
| Thu, 11 Sep 2025 | ₹3.2t | ₹331.4b | ₹45.5b | 49.4x | 69.3x | 9.5x |
| Sat, 09 Aug 2025 | ₹3.1t | ₹327.2b | ₹44.1b | 51.4x | 69.7x | 9.4x |
| Mon, 07 Jul 2025 | ₹2.9t | ₹300.7b | ₹37.2b | 45.3x | 79.2x | 9.8x |
| Wed, 04 Jun 2025 | ₹2.8t | ₹299.9b | ₹37.2b | 46.2x | 75.7x | 9.4x |
| Fri, 02 May 2025 | ₹2.6t | ₹288.4b | ₹30.7b | 46.8x | 84.8x | 9x |
| Sun, 30 Mar 2025 | ₹2.6t | ₹287.4b | ₹30.8b | 45.3x | 84x | 9x |
| Tue, 25 Feb 2025 | ₹2.5t | ₹287.4b | ₹30.8b | 48x | 80.4x | 8.6x |
| Thu, 23 Jan 2025 | ₹2.5t | ₹269.1b | ₹30.1b | 48.7x | 82.2x | 9.2x |
| Sat, 21 Dec 2024 | ₹2.5t | ₹269.1b | ₹30.1b | 49.9x | 82.6x | 9.2x |
| Mon, 18 Nov 2024 | ₹2.3t | ₹254.1b | ₹28.8b | 47.8x | 80.4x | 9.1x |
| Wed, 16 Oct 2024 | ₹2.5t | ₹247.6b | ₹26.3b | 51.7x | 93.7x | 9.9x |
| Fri, 13 Sep 2024 | ₹2.3t | ₹247.6b | ₹26.3b | 53x | 88.5x | 9.4x |
| Sun, 11 Aug 2024 | ₹1.9t | ₹206.4b | ₹24.8b | 35.8x | 77.5x | 9.3x |
| Tue, 09 Jul 2024 | ₹1.8t | ₹202.0b | ₹23.9b | 36.6x | 73.8x | 8.7x |
| Thu, 06 Jun 2024 | ₹1.7t | ₹195.5b | ₹21.5b | 32.3x | 79.1x | 8.7x |
| Sat, 04 May 2024 | ₹1.5t | ₹167.8b | ₹18.7b | 29.9x | 78x | 8.7x |
| Mon, 01 Apr 2024 | ₹1.3t | ₹168.5b | ₹18.6b | 27.4x | 71.2x | 7.9x |
| Wed, 28 Feb 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 32.1x | 74x | 8.2x |
| Fri, 26 Jan 2024 | ₹1.4t | ₹165.9b | ₹18.9b | 30.5x | 72.2x | 8.2x |
| Sun, 24 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.3x | 75.1x | 8.7x |
| Tue, 21 Nov 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.4x | 75.2x | 8.7x |
| Thu, 19 Oct 2023 | ₹1.3t | ₹156.2b | ₹19.8b | 26.9x | 68x | 8.6x |
| Sat, 16 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.4x | 73.1x | 9.3x |
| Mon, 14 Aug 2023 | ₹1.4t | ₹160.1b | ₹23.2b | 22.8x | 59.9x | 8.7x |
Price to Earnings Ratio
59.9x
Current Industry PE
- Investors are relatively neutral on the Indian Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 74.7x.
- The 3-year average PS ratio of 9.0x is lower than the industry's current PS ratio of 10.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 29% per year over the last three years.
- Revenues for these companies have grown 32% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Clinical Research and Equipment compare with similar industries?
| IN Market | 1.87% | |
| Healthcare | 0.72% | |
| Life Sciences | 4.98% | |
| Clinical Research and Equipment | 4.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹8.28k | 2.7% +₹58.1b | 39.9% | PE75.1x | |
| ANTHEM Anthem Biosciences | ₹841.00 | 3.9% +₹17.9b | 15.3% | PE82.2x | |
| SAILIFE Sai Life Sciences | ₹1.37k | 3.8% +₹10.6b | 64.9% | PE80.1x | |
| INDGN Indegene | ₹554.45 | 7.6% +₹9.5b | -2.9% | PE33.3x | |
| SYNGENE Syngene International | ₹403.70 | 4.6% +₹7.1b | -38.4% | PE72.7x |
